SSB
FPRX

Sandy Spring Bank’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Sandy Spring Bank’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-200
Closed -$1K – 1007
2020
Q2 		$1K Buy
+200
New +$824 ﹤0.01% 892

Other funds holding FPRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Sandy Spring Bank's FPRX Position: Q3 2020 in Review

Sandy Spring Bank sold out of Five Prime Therapeutics, Inc. (FPRX) in Q3 2020, closing a stake of 200 shares — an estimated $1K sold.

Sandy Spring Bank first reported a position in FPRX in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 94 funds tracked by Wall St. Rank hold FPRX as of Q3 2020.

  • Sandy Spring Bank reported no remaining Five Prime Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
  • Sandy Spring Bank sold 200 Five Prime Therapeutics, Inc. shares in Q3 2020, an estimated $1K.
  • Sandy Spring Bank first reported a position in Five Prime Therapeutics, Inc. in Q2 2020 and held it in 1 quarter.
  • Sandy Spring Bank's Five Prime Therapeutics, Inc. position peaked at $1K in Q2 2020.
  • 94 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q3 2020.

Based on Sandy Spring Bank's 13F filing for Q3 2020, filed 9 Nov 2020.